BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/7/2017 7:22:42 AM | Browse: 2150 | Download: 4269
 |
Received |
|
2017-02-04 15:32 |
|
Peer-Review Started |
|
2017-02-12 14:23 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2017-03-07 10:34 |
|
Revised |
|
2017-03-17 17:21 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2017-04-27 11:58 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2017-05-04 18:45 |
|
Articles in Press |
|
2017-05-04 18:45 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-05-25 03:40 |
|
Publish the Manuscript Online |
|
2017-06-07 07:22 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Basic Study |
| Article Title |
Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C
|
| Manuscript Source |
Invited Conference Manuscripts |
| All Author List |
Bogna Świątek-Kościelna, Ewelina Kałużna, Ewa Strauss, Jerzy Nowak, Iwona Bereszyńska, Ewelina Gowin, Jacek Wysocki, Jolanta Rembowska, Dominika Barcińska, Iwona Mozer-Lisewska and Danuta Januszkiewicz-Lewandowska |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Danuta Januszkiewicz-Lewandowska, MD, PhD, Professor, Department of Pediatric Oncology, Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Szpitalna 27/33, 60-572 Poznan, Poland. danuta.januszkiewicz@ump.edu.pl |
| Key Words |
Hepatitis C virus; Chronic hepatitis C; Interferon lambda 3; Interleukin 28B; rs4803217 |
| Core Tip |
The rs4803217 single nucleotide polymorphism of IFNL3 (IL28B) gene, which encodes, interferon lambda 3 (interleukin 28B), has been proposed as a causal variant that may influence hepatitis C virus (HCV) clearance. In the present study it was found that rs4803217 is a strong and independent predictor of sustained virological response and relapse in HCV genotype 1 infected chronic hepatitis C patients treated with pegylated interferon alpha and ribavirin. Moreover, it was indicated that rs4803217 seems to be much better predictor of therapy outcome than well-establish IFNL3 SNPs (rs12979860, rs8099917 and rs12980275). |
| Publish Date |
2017-06-07 07:22 |
| Citation |
Świątek-Kościelna B, Kałużna E, Strauss E, Nowak J, Bereszyńska I, Gowin E, Wysocki J, Rembowska J, Barcińska D, Mozer-Lisewska I, Januszkiewicz-Lewandowska D. Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C. World J Gastroenterol 2017; 23(21): 3815-3824 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i21/3815.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i21.3815 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
